News

A specific form of magnesium taken orally and able to readily enter the brain was seen to ease Parkinson’s-related motor problems and nerve cell loss in a mouse model of the disorder. The study, “Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits…

Parkinson’s disease may be classified by into two distinct subtypes based on where in the nervous system the disease starts, a study proposes. Its findings could have major implications for the development of new treatments. The paper, “Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis,” was published in…

Exposure to pesticides, severe head injury with fainting, and consumption of soda, nuts and red meat appear to be risk factors for Parkinson’s disease among people in Cyprus, a Mediterranean island with an interesting genetic mix, a study suggests. Study results further suggest that smoking and…

The early detection of diseases characterized by protein misfolding and aggregation, such as Parkinson’s disease, moved one step closer by the validation in animal models of a sensitive technique to capture and analyze misfolded and aggregated proteins in the blood quickly and efficiently.

People with severe non-motor symptoms related to Parkinson’s disease (PD) have a smaller thalamus compared to those with similar but mild to moderate symptoms, a brain imaging study suggests. Sleeping and gastrointestinal problems are also tied to atrophy (shrinking)…

A wrist-worn medical device — called the Personal KinetiGraph or PKG — that reminds people with Parkinson’s disease to take their medication, and records their movements to provide physicians with objective measurements of motor symptoms, showed great promise as a tool to improve clinical decision-making, a study found.

The Parkinson’s Foundation is launching a new initiative called Parkinson’s Revolution, a global cycling event designed to highlight the benefits of exercise in Parkinson’s disease while also raising funds for research. A new signature event for the foundation, Parkinson’s Revolution is an indoor cycling program taking place Feb. 8…

Medtronic, a medical technology company, announced that its Activa patient programmer technology for deep brain stimulation (DBS) therapy is now available to U.S. patients with Parkinson’s disease (PD) and other movement disorders. The new programmer, approved by the FDA in July, is used with a customized…

Inappropriate antipsychotic medications — those approved for ills like schizophrenia but used to treat depression — given to elderly people with Parkinson’s disease increase their risk of pneumonia, a study suggests. The study, “Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson’s…

Parkinson’s UK and Alzheimer’s Research UK have teamed up to help fund a project that will test whether a “waste disposal system” in the brain could be exploited to help in the understanding and treatment of these diseases, Parkinson’s UK announced. The new project, which is expected to…